Real-time enrollment status for this primary immunodeficiencies clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT02579967 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunodeficiencies |
| Phase | Clinical Trial |
| Target Enrollment | 254 participants |
| Active Locations | 2 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT02579967 is currently recruiting participants. This clinical trial study for primary immunodeficiencies is actively seeking new participants at 2 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02579967 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02579967 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.